A. Todd
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Gastric Cancer Management and Outcomes 1
- Oncology 8
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Yuri Rukazenkov (6 shared papers)Juliann Chmielecki (3 shared papers)Riyaz Shah (2 shared papers)Margarita Majem (3 shared papers)Aleksandra Markovets (3 shared papers)Fumio Imamura (2 shared papers)Jhanelle E. Gray (3 shared papers)Byoung Chul Cho (3 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Thoracic Oncology (2 papers)ESMO Open (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- JapanSouth KoreaUnited Kingdom
In The Last Decade
A. Todd
8 papers receiving 337 citations
A. Todd's Hit Papers
Peers
Comparison fields: 5 of 16
- Pulmonary and Respiratory Medicine 323
- Oncology 252
- Cancer Research 84
- Molecular Biology 124
- Pathology and Forensic Medicine 30
Countries citing papers authored by A. Todd
This map shows the geographic impact of A. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Todd more than expected).
Fields of papers citing papers by A. Todd
This network shows the impact of papers produced by A. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Todd. The network helps show where A. Todd may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Todd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study Hit paper breakdown → | 2018 | 269 |
| 2 | 2018 | 28 | |
| 3 | 2019 | 13 | |
| 4 | 2018 | 13 | |
| 5 | 2024 | 13 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 2 | |
| 8 | 2025 | 1 |
About A. Todd
A. Todd is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Hematology and Cancer Research, having authored 8 papers that have together received 343 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (323 citations), Oncology (252 citations), Cancer Research (84 citations), Molecular Biology (124 citations) and Pathology and Forensic Medicine (30 citations). A. Todd has collaborated with scholars based in Japan, South Korea and United Kingdom. Frequent co-authors include Yuri Rukazenkov, Juliann Chmielecki, Riyaz Shah, Margarita Majem, Aleksandra Markovets, Fumio Imamura, Jhanelle E. Gray, Byoung Chul Cho, C. Zhou and Suresh S. Ramalingam. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, ESMO Open and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.